Ashis Kumar Samanta

Ashis Kumar Samanta

Auto-generated profile, based on publicly available information

Ashis Kumar Samanta

Animal Science Division, Indian Council of Agricultural Research, New Delhi, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Industrial Crops and Products
Verified
Journal Article
Closed access
NJNatasha Jayapal
Natasha Jayapal
ASA.K. Samanta
A.K. Samanta
AKAtul P. Kolte
Atul P. Kolte
SSS. Senani
S. Senani
MSManpal Sridhar
Manpal Sridhar
KSK.T. Sampath
K.T. Sampath

1 July 2012 in Food and Bioproducts Processing
Verified
Journal Article
Closed access
ASA.K. Samanta
A.K. Samanta
SSS. Senani
S. Senani
AKAtul P. Kolte
Atul P. Kolte
MSManpal Sridhar
Manpal Sridhar
KSK.T. Sampath
K.T. Sampath
ADAnusuya Devi
Anusuya Devi

18 October 2018 in Journal of Food Science
Verified
Journal Article
Open access
PDF file
SRSohini Roy
Sohini Roy
JCJayaram Chikkerur
Jayaram Chikkerur
SRSudhir Chandra Roy
Sudhir Chandra Roy
ADArindam Dhali
Arindam Dhali
AKAtul Puroshtam Kolte
Atul Puroshtam Kolte
ASAshis Kumar Samanta
Ashis Kumar Samanta
Nutraceuticals are gaining importance owing to their potential applications in numerous sectors including food and feed industries. Among the emerging nutraceuticals, d ‐tagatose occupies a significant niche because of its low calorific value, antidiabetic property and growth promoting effects on beneficial gut bacteria. As d ‐tagatose is present in minute quantities in naturally occurring food substances, it is produced mainly by chemical or biological means. Recently, attempts were made for bio‐production of d ‐tagatose using l ‐arabinose isomerase enzyme to overcome the challenges of chemical process of production. Applications of d ‐tagatose for maintaining health and wellbeing are increasing due to growing consumer awareness and apprehension against modern therapeutic agents. This review outlines the current status on d ‐tagatose, particularly its production, properties, biological role, applications, and the future perspectives.

1 May 2012 in Bioresource Technology
Verified
Journal Article
Closed access
ASA.K. Samanta
A.K. Samanta
NJNatasha Jayapal
Natasha Jayapal
AKA.P. Kolte
A.P. Kolte
SSS. Senani
S. Senani
MSManpal Sridhar
Manpal Sridhar
KSK.T. Sampath
K.T. Sampath

1 January 2013 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ASA.K. Samanta
A.K. Samanta
NJNatasha Jayapal
Natasha Jayapal
SSS. Senani
S. Senani
AKA.P. Kolte
A.P. Kolte
MSManpal Sridhar
Manpal Sridhar
In recent years, there has been a growing appreciation on the relevance of gastrointestinal microflora in both ruminants and non-ruminants owing to revelation of their role in several physiological functions including digestion, nutrient utilization, pathogen exclusion, gastrointestinal development, immunity system, gut gene expression and quality of animal products. The ban imposed on the use of antibiotics and hormones in feed has compelled animal researchers in finding an alternative which could overcome the issues of conventional feed additives. Though the concept of prebiotic was evolved keeping in mind the gastrointestinal flora of human beings, presently animal researchers are exploring the efficiency of prebiotic (inulin) for modulating the gut ecosystem of both ruminants and non-ruminants. It was revealed that prebiotic inulin is found to exhibit desirable changes in the gut of non-ruminants like poultry, swine, rabbit etc for augmenting gut health and improvement of product quality. Similarly, in ruminants the prebiotic reduces rumen ammonia nitrogen, methane production, increase microbial protein synthesis and live weight gains in calves. Unlike other feed additives, prebiotic exhibits its effect in multipronged ways for overall increase in the performances of the animals. In coming days, it is expected that prebiotics could be the part of diets in both ruminants and non-ruminants for enabling modulation of gut microflora vis a vis animals productivity in ecological ways.

27 April 2012 in Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
ASAshis K. Samanta
Ashis K. Samanta
VTValeria Torok
Valeria Torok
NPNigel J. Percy
Nigel J. Percy
SASuzanne M. Abimosleh
Suzanne M. Abimosleh
Gordon HowarthGordon Howarth
Gordon Howarth
An abnormal composition of the gut microbiota is believed to be associated with the pathogenesis of inflammatory bowel disease (IBD). We utilized terminal restriction fragment length polymorphism (T-RFLP) analysis to quantify faecal bacterial communities from rats with experimental colitis. Male Sprague Dawley rats (n=10/group) ingested 2% dextran sulfate sodium (DSS) or water for up to 7 days. Rats were killed and colonic tissues collected for histological analysis. Damage severity score in the distal colon was significantly greater (P<0.001) following DSS consumption compared to controls. T-RFLP faecal bacterial profiles generated with either MspI or CfoI revealed a significant difference (P<0.001) in community composition between healthy and colitic rats, with bacterial composition in healthy rats more variable than in rats with colitis. Operational taxonomic units (OTU: taxonomically related groups of bacteria) associated with either the healthy or colitic state were identified. OTU (116, 226, 360, and 948; CfoI) and (118 and 188; MspI) were strongly associated with untreated healthy rats, while OTU (94, 98, 174, and 384; CfoI) and (94 and 914; MspI) were predominantly associated with DSS-treated colitic rats. Phylogenetic OTU assignment suggested that Bacteroidales and Lactobacillus sp. were predominantly associated with the colitic and healthy rats, respectively. These results show that faecal bacterial profiling is a rapid, sensitive and non-invasive tool for detecting and identifying changes in gut microbiota associated with colitis. Restoring microbial homeostasis by targeting colitis-associated OTU through specific microbiological interventions could form the basis of novel therapeutic strategies for IBD.